Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent changes in the drug treatment of allergic asthma.

Clinical medicine (London, England) - 1 Oct 2013

Gibeon David, Menzies-Gow Andrew

Abstract excerpt

Asthma is a heterogeneous condition with multiple phenotypes that respond to treatments in different ways. Allergic asthma is an important phenotype and although currently available treatments are effective, about 5% of affected patients have severe, treatment-refractory disease. Despite advances...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Adrenergic beta-Agonists
Share to Anti-Asthmatic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asthma

Share to Immunotherapy

Share to Muscarinic Antagonists

Share to Quality of Life

Share to Th2 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 24115705
DOI: 10.7861/clinmedicine.13-5-477
PMCID: PMC4953799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24115705-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent changes in the drug treatment of allergic asthma.PMID 24115705Read ↗

New approaches for identifying and testing potential new anti-asthma agents.Semantic proximity Read ↗

Future treatment for asthma.Semantic proximity Read ↗

Molecular allergology approach to allergic asthma.Semantic proximity Read ↗

Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives.Semantic proximity Read ↗

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Semantic proximity Read ↗

Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) In Paediatric Severe Allergic Asthma – A Romanian PerspectiveSemantic proximity Read ↗

Pros and cons: Should AIT be considered in all patients with allergic asthma?Semantic proximity Read ↗

Evidence for phenotype-driven treatment in asthmatic patients.Semantic proximity Read ↗

Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma.Semantic proximity Read ↗

Biological treatment provides disease-modifying immunological effectsSemantic proximity Read ↗

Drug development for asthma.Semantic proximity Read ↗

Reslizumab and Eosinophilic Asthma: One Step Closer to Phenotype-directed Therapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.